Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04258787 · ClinicalTrials.gov registry record
OCT in Fuchs' Dystrophy
A clinical trial of Fuchs Dystrophy and Pseudophakic Bullous Keratopathy, sponsored by Oregon Health and Science University.
- Recruiting
- Registry status
- 60
- Enrollment target
- 1
- Study location
NCT04258787: Recruiting study of Fuchs Dystrophy and Pseudophakic Bullous Keratopathy, sponsored by Oregon Health and Science University.
NCT04258787 is a study of Fuchs Dystrophy and Pseudophakic Bullous Keratopathy that is actively recruiting participants, run by Oregon Health and Science University. The registered enrollment target is 60 participants. The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04258787, a study of Fuchs Dystrophy and Pseudophakic Bullous Keratopathy, is actively recruiting participants, sponsored by Oregon Health and Science University.
- RECRUITING
- Registry status
- 60 participants
- Enrollment target
- 1
- Study location
Study Summary
This is an observational study using optical coherence tomography (OCT) technology to quantify corneal edema in Fuchs' endothelial dystrophy and predict refractive shift from resolving corneal edema after surgical treatments.
Primary Outcome
OCT will be used to measure corneal epithelial edema/haze (in microns) in participants with Fuchs' or PBK
Conditions Studied
Study Locations (1)
Oregon
- Oregon Health & Science University - Portland
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 60 participants |
| Start Date | 2020-06-26 |
| Est. Completion | 2028-06 |
What NCT04258787 shows while recruiting
NCT04258787 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 60 participants, a relatively small participant target.
The record links to 2 conditions, with Fuchs Dystrophy appearing as the primary indexed condition, and to 0 interventions.
NCT04258787 reports a single indexed study location in Oregon.
Frequently Asked Questions
What is clinical trial NCT04258787 about?
NCT04258787 is a clinical study titled "OCT in Fuchs' Dystrophy". This is an observational study using optical coherence tomography (OCT) technology to quantify corneal edema in Fuchs' endothelial dystrophy and predict refractive shift from resolving corneal edema after surgical treatments.
What is the current status of trial NCT04258787?
This trial is currently recruiting. The enrollment target is 60 participants. The study started on 2020-06-26. Estimated completion is 2028-06.
What conditions does trial NCT04258787 study?
This clinical trial studies the following conditions: Fuchs Dystrophy, Pseudophakic Bullous Keratopathy.
Who is sponsoring clinical trial NCT04258787?
This trial is sponsored by Oregon Health and Science University, which has 546 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04258787 being conducted?
This trial has 1 study location across Oregon. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Fuchs Dystrophy
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00576069 · 60 participants
Mechanism(s)of Airflow Limitation in Moderate-severe Persistent Asthma
- NCT01297400 · 60 participants · Phase 2
Phase 2 Pilot Study of the Safety and Efficacy of Topical MW-III in Thermal Burns
- NCT01734122 · 60 participants
Stereotactic Radiosurgery for Essential Tremor and Parkinsonian Tremor
- NCT01804634 · 60 participants · Phase 2
Reduced Intensity Haploidentical BMT for High Risk Solid Tumors
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI